Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICS/LABA vs LAMA in COPD Stratified by eNO Levels
NCT02546349Phase 4Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jul 2014
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol + fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by Taipei Veterans General Hospital. Status: unknown.
02
Drugs
salmeterol + fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02546349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02546349.